Patents by Inventor Jiri Honiger

Jiri Honiger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof
    Publication number: 20060210635
    Abstract: The invention relates to injectable gel-forming compositions which contain an association of linear and cross-linked polymers and are embodied in the form of a suspension. The use of said compositions, in particular for filling pipes and cavities is also disclosed.
    Type: Application
    Filed: January 5, 2004
    Publication date: September 21, 2006
    Applicants: ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, UNIVERSITE PARIS SUD XI
    Inventors: Alexandre Laurent, Denis Labarre, Jiri Labsky, Jiri Honiger, Rene Chapot, Michel Wassef, Aymeric Seron
  • Biocompatible polymer with a three-dimensional structure with communicating cells, a process for its preparation, and application in medicine and in surgery
    Publication number: 20040062809
    Abstract: Disclosed are porous biocompatible polymers in the form of hydrogels, methods of preparing the hydrogels, and methods of using the hydrogels, e.g., in vitro cell culture and body implants.
    Type: Application
    Filed: December 26, 2002
    Publication date: April 1, 2004
    Applicant: Universite Pierre et Marie Curie (Paris VI)
    Inventors: Jiri Honiger, Andre Apoil
  • Intraocular transplantation of encapsulated cells
    Patent number: 6663894
    Abstract: Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition comprising encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-angiogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: December 16, 2003
    Assignees: Universite de Paris V Rene-Descartes, Association Francaise Retinitis Pigmentosa
    Inventors: Marc Abitbol, Yves Uteza, Maurice Menasche, Carine Bossard, Loic Van Den Berghe, Sebastian Bonnel, Hervé Prats, Jiri Honiger, Martin Neuner-Jehle
  • Intraocular transplantation of encapsulated cells
    Patent number: 6500449
    Abstract: Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition comprising encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-angiogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: December 31, 2002
    Assignees: Universite de Paris V Rene-Descartes, Association Francaise Retinitis Pigmentosa
    Inventors: Marc Abitbol, Yves Uteza, Maurice Menasche, Carine Bossard, Loïc Van Den Berghe, Sébastian Bonnel, Hervé Prats, Jiri Honiger, Martin Neuner-Jehle
  • Intraocular transplantation of encapsulated cells
    Publication number: 20020076396
    Abstract: Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition comprising encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-angiogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.
    Type: Application
    Filed: February 1, 2001
    Publication date: June 20, 2002
    Applicant: Universite de Paris V Rene-Descartes
    Inventors: Marc Abitbol, Yves Uteza, Maurice Menasche, Carine Bossard, Loic Van Den Berghe, Sebastian Bonnel, Herve Prats, Jiri Honiger, Martin Neuner-Jehle
  • Intraocular transplantation of encapsulated cells
    Publication number: 20020076397
    Abstract: Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition comprising encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-angiogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.
    Type: Application
    Filed: February 1, 2001
    Publication date: June 20, 2002
    Applicant: Universite de Paris V Rene-Descartes
    Inventors: Marc Abitbol, Yves Uteza, Maurice Menasche, Carine Bossard, Loic Van Den Berghe, Sebastian Bonnel, Herve Prats, Jiri Honiger, Martin Neuner-Jehle
  • Intraocular transplantation of encapsulated cells
    Patent number: 6267954
    Abstract: Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-anglogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: July 31, 2001
    Assignees: Universite de Paris V Rene-Descartes, Association Francaise Retinitis Pigmentosa
    Inventors: Marc Abitbol, Yves Uteza, Maurice Menasche, Carine Bossard, Loïc Van Den Berghe, Sébastien Bonnel, Hervé Prats, Jiri Honiger, Martin Neuner-Jehle